abstract |
Use of vertebrate vascular-endothelial protein tyrosine phosphatases (i.e.: murine phosphatase VE-PTP or human phosphatase HPTPβ) or portions thereof for the manufacture of an agent for monitoring or β modulating the activity of the angiopoietin receptor-type tyrosine kinase Tie-2. |